Follow the VRX stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, VRX has published 5 reports. Market capitalisation: €39.4m. The latest transaction was filed on 20 July 2026 (Change in Substantial Holding). Among the most active insiders: Sparta Invest AG, Heidelberg, Germany. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
VRX is a company operating in the health and pharmaceutical sector, listed on the XASX market. It focuses on the development and commercialization of innovative solutions for patient well-being.